HoFH: The need to treat - creating awareness, understanding and insights

This online series consist of three presentations by lipid experts, who present evidence for the need to treat patients with homozygous FH (HoFH).

Episodes 1-3 of 3

  • Novel LDLc lowering therapies What is the potential for ANGPTL inhibition in HoFHNovel LDLc lowering therapies What is the potential for ANGPTL inhibition in HoFH
    HoFH: The need to treat - creating awareness, understanding and insights
    Novel LDL-c lowering therapies: What is the potential for ANGPTL3 inhibition in HoFH?
    • Prof. Frederick Raal
      Prof. Frederick Raal

      Prof. Frederick Raal

  • Optimizing treatment for patients with HoFHOptimizing treatment for patients with HoFH
    HoFH: The need to treat - creating awareness, understanding and insights
    Optimizing treatment for patients with HoFH
    • Prof. Erik Stroes, MD
      Prof. Erik Stroes, MD

      Prof. Erik Stroes, MD

  • HoFH Why is early diagnosis importantHoFH Why is early diagnosis important
    HoFH: The need to treat - creating awareness, understanding and insights
    HoFH: Why is early diagnosis important?
    • Prof Kausik Ray
      Prof Kausik Ray

      Prof Kausik Ray

Register

We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free